IRIS
LOMBARDO, ANGELO LEONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.807
AS - Asia 1.592
NA - Nord America 1.584
SA - Sud America 278
AF - Africa 41
OC - Oceania 2
Totale 5.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.507
RU - Federazione Russa 1.064
CN - Cina 533
SG - Singapore 525
BR - Brasile 227
HK - Hong Kong 217
SE - Svezia 197
IT - Italia 166
VN - Vietnam 136
DE - Germania 96
FR - Francia 78
GB - Regno Unito 61
CA - Canada 44
IN - India 36
BD - Bangladesh 34
MX - Messico 24
PL - Polonia 23
ZA - Sudafrica 23
FI - Finlandia 21
AT - Austria 19
ES - Italia 18
IQ - Iraq 18
JP - Giappone 18
NL - Olanda 18
AR - Argentina 15
ID - Indonesia 12
CO - Colombia 10
EC - Ecuador 9
IE - Irlanda 9
LT - Lituania 9
PK - Pakistan 9
TR - Turchia 8
IR - Iran 6
MA - Marocco 6
PT - Portogallo 6
VE - Venezuela 6
CH - Svizzera 5
IL - Israele 5
AE - Emirati Arabi Uniti 4
NP - Nepal 4
TH - Thailandia 4
BG - Bulgaria 3
KE - Kenya 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
UA - Ucraina 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
BE - Belgio 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
PE - Perù 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
IM - Isola di Man 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.304
Salva come PNG Salva come JPEG
Città #
Ashburn 271
Singapore 253
Moscow 239
Hong Kong 210
Dallas 206
San Jose 157
New York 98
Shanghai 93
Beijing 92
Hefei 66
Lauterbourg 57
Los Angeles 56
Milan 52
Lawrence 47
Princeton 47
Ho Chi Minh City 40
Hanoi 35
Orem 33
Washington 30
Munich 27
São Paulo 24
Boardman 23
Warsaw 21
Nuremberg 20
Denver 19
Council Bluffs 17
Montreal 17
Tokyo 16
Brooklyn 15
Johannesburg 15
San Francisco 15
Santa Clara 15
Stockholm 15
Atlanta 14
Houston 14
Chennai 13
The Dalles 13
Guangzhou 12
Boston 11
Mexico City 11
Phoenix 11
Seattle 11
Toronto 11
Da Nang 10
Helsinki 10
Poplar 10
Baghdad 9
Chicago 9
Falkenstein 9
London 9
Manchester 9
Rome 9
Turku 9
Frankfurt am Main 8
Haiphong 8
Jiaxing 8
Perugia 8
Dublin 7
Hangzhou 7
Shenzhen 7
Amsterdam 6
Bogotá 6
Curitiba 6
Mumbai 6
New Delhi 6
Rio de Janeiro 6
Vienna 6
Charlotte 5
Columbus 5
Monza 5
Barcelona 4
Belo Horizonte 4
Bologna 4
Genoa 4
Lannion 4
Omaha 4
Ottawa 4
Philadelphia 4
Reston 4
Rishon LeTsiyyon 4
Salvador 4
Tianjin 4
Xi'an 4
Zhengzhou 4
Ankara 3
Annapolis 3
Aveiro 3
Bangkok 3
Berlin 3
Biggleswade 3
Buffalo 3
Caraguatatuba 3
Dhaka 3
Ferrara 3
Franca 3
La Plata 3
Lyon 3
Manassas 3
Montevideo 3
Nairobi 3
Totale 2.769
Salva come PNG Salva come JPEG
Nome #
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering 144
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing 136
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes 124
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 118
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice 117
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
Permanent Epigenetic Gene Silencing 114
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors 111
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement 110
SELECTION BY MEANS OF ARTIFICIAL TRANSACTIVATORS 109
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 108
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 106
An unbiased genome-wide analysis of zinc-finger nuclease specificity 106
COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION 103
GENE SILENCING 103
Gene Modification and Three-Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches 100
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing 99
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 96
Genome editing: a tool for research and therapy: Targeted genome editing hits the clinic 95
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway 95
Epigenome-editing strategies to enhance oligodendroglial differentiation from human induced pluripotent stem cells 93
Altered Cl− homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability 90
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 89
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells 86
A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels 86
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis 86
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF 83
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 83
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 82
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 81
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy 81
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes 78
VECTOR PRODUCTION 78
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 78
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes 77
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. 76
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery 76
Methods and compositions for targeted integration 75
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 74
Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose 73
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 73
Site-specific integration and tailoring of cassette design for sustainable gene transfer 72
In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors 69
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 68
Targeted genome editing in human repopulating haematopoietic stem cells 67
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 67
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1 67
Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice 66
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy 64
Targeting Integration to Selected Genomic Loci and In Situ Tailoring of Cassette Design Allows Robust Transgene Expression without Perturbing Endogenous Transcription 63
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 62
Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector 61
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 61
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 61
Trattamento chirurgico della fibrillazione atriale associata a valvulopatia mitralica. “Maze Procedure” e chirurgia della mitrale. 60
Genomic instability in induced stem cells 59
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency 58
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice 58
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 57
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients. 56
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 54
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 54
Targeted gene therapy and cell reprogramming in Fanconi anemia 53
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity 50
NY-ESO-1 Single Edited T Cells to Treat Multiple Myeloma without Inducing GvHD 49
Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A 49
The immune response to lentiviral-delivered transgene is modulated in vivo by transgene expressing antigen presenting cells but not by CD4+CD25+ regulatory T cells 43
Totale 5.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 19 2 0 5 0 3 0 0 3
2022/2023293 101 76 24 3 2 42 8 23 6 2 6 0
2023/2024348 2 15 38 59 41 99 4 21 2 11 16 40
2024/20251.156 93 16 29 79 74 106 196 114 183 82 86 98
2025/20263.495 262 242 221 481 363 118 289 262 946 147 69 95
2026/202732 32 0 0 0 0 0 0 0 0 0 0 0
Totale 5.456